DOCSLIB.ORG

Substance Abuse Treatment and Care for Women: Case Studies and Lessons Learned

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Substance Abuse Treatment and Care for Women: Case Studies and Lessons Learned BackB to navigation page Vienna International Centre, PO Box 500, A 1400 Vienna, Austria Tel: +(43) (1) 26060-0, Fax: +(43) (1) 26060-5866, www.unodc.org Substance abuse treatment and care for women: Case studies and lessons learned Printed in Austria V.04-55683—November 2004—1,150 Drug Abuse Treatment Toolkit Drug Abuse Treatment United Nations publication Sales No. E.04.XI.24 ISBN 92-1-148194-5 UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Substance abuse treatment and care for women: Case studies and lessons learned UNITED NATIONS New York, 2004 The United Nations Office on Drugs and Crime would like to thank the Smithers Foundation for its generous contribution towards the cost of publishing this report. Vienna, August 2004 UNITED NATIONS PUBLICATION Sales No. E.04.XI.24 ISBN 92-1-148194-5 The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations con- cerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Acknowledgements The present publication was commissioned by the insights on the lessons learned in the implementa- United Nations Office on Drugs and Crime tion of their projects; (UNODC), Global Challenges Section. • The members of the panel of experts, who provi- ded their insights and feedback to earlier drafts; The United Nations Office on Drugs and Crime • The drug demand reduction experts and focal points expresses its gratitude to the following: at the regional and country offices of the United Nations Office on Drugs and Crime, who shared • The staff of all treatment services who, despite a their knowledge about treatment services for women heavy workload, took the time to provide answers in their regions and made recommendations on to the survey among candidate projects; the projects to be included in the booklet. • The contributors to the present volume who pro- vided detailed information on their work and an The United Nations Office on Drugs and Crime also in-depth analysis of their projects with regard to wishes to acknowledge the contribution of Virginia various criteria. Included in these thanks are the Carver, the project consultant, who identified the case staff working on the projects; studies, facilitated the meeting in Vienna and com- piled the draft publication; also Pilar Cuellar and My • The participants of the meeting held in Vienna in Hue McGowran, who supported the meeting and edi- December 2003, who shared their experiences and torial process. iii Panel of Experts Susan Beckerleg, Kenya Maristela Monteiro, World Health Organization/ Jan Copeland, Australia Pan American Health Organization Stephanie Covington, United States of America Pratima Murthy, India Marie Louise Ernst, Switzerland Dace Svikis, United States of America Gabriele Fischer, Austria Nancy Usher, Canada Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction Irmgard Vogt, Germany Anna Chisman, Inter-American Drug Abuse Control Cora-Lee Wetherington, National Institute on Drug Commission Abuse, United States of America Case study representatives Silvia Brasiliano and Patricia Hochgraf (Brazil) Murièle Lasserre Bergerioux (Switzerland) Dr. Miguel Cedeño (Panama) Lotta Länne (Sweden) Abdoulaye Diouf (Senegal) Margaret Leslie (Canada) Karin Goger (Austria) Ashita Mittal (India) Ann Harrison (United States of America) Harlie Outhwaite, Nellie Manley and Colleen Allan Christine Heinrichs (Germany) (Canada) Katarina Jiresova (Slovakia) Barbara Rich (Australia) Kamil Kalina and Jiri Richter (Czech Republic) Elizabeth Selhore (India) Karol Kaltenbach (United States of America) Sepideh Sigara (Islamic Republic of Iran) Jehanzeb Khan and David MacDonald (Afghanistan; Wendee Wechsberg (United States of America) Pakistan) Martha J. Wright (United States of America) Marcela Lara Orellana (Chile) iv Preface The present booklet is about gender-responsive sub- their treatment needs. Women with substance use stance abuse treatment services for women. It is part problems also experience significant barriers to access- of the United Nations Office on Drugs and Crime ing treatment, and are believed to be underrepresen- (UNODC) project to develop tools to support the ted in treatment settings. Cultural taboos and stigma development and improvement of substance abuse mean their substance use problems are often not treatment services, based on evidence from the literature acknowledged by themselves, their families or helping and case studies that illustrate practical experiences professionals who could support them in seeking and lessons learned in providing substance abuse treatment. Pregnant and parenting women using sub- treatment services in various regions of the world. stances face particular societal condemnation, and Other publications in this Drug Abuse Treatment pregnant women often delay seeking services with Toolkit series are: Investing in Drug Abuse Treatment: a serious implications for the mother and the foetus. Discussion Paper for Policy Makers; Contemporary Drug Women who are parents usually have primary respon- Abuse Treatment: a Review of the Evidence Base; and sibility for childcare, as well as other household Drug Abuse Treatment and Rehabilitation: a Practical responsibilities. However, few treatment services pro- Planning and Implementation Guide.* These can be vide childcare, and in some cultures it is very difficult found on the UNODC web site (www.unodc.org/ for women to leave their homes and family responsi- unodc/en/treatment_toolkit.html). bilities to seek treatment. The project on women’s substance abuse treatment More often than men, women have been introduced services was launched in response to the Declaration to substances and continue to use substances with on the Guiding Principles of Drug Demand their spouses or partners, who may also be physically Reduction (General Assembly resolution S-20/3, or sexually abusive. With little emotional support, or annex) and the measures to enhance international financial resources to pay for treatment, childcare or cooperation to counter the world drug problem transportation, women find it difficult to enter and (Assembly resolutions S-20/4 A to E), adopted by the remain in treatment. Women also have more severe General Assembly at its twentieth special session. The problems at treatment entry than men. Many have Guiding Principles indicate that demand reduction experienced trauma and use substances to cope with programmes should be designed to address the needs these experiences. They are more likely to have men- of the population in general, as well as specific popu- tal health problems such as anxiety or depression or lation groups. post-traumatic stress disorder than men. They also have fewer resources in terms of education, employ- In most countries of the world, the circumstances of ment and finances. At the same time, because more women’s lives are very different from those of men. men than women use illicit and other substances of This is also reflected in their experience of substance abuse, most treatment programmes have been use problems. Women’s substance use problems are designed with men in mind and do not take into more stigmatized and less likely to be acknowledged account gender differences. The goal of this publica- than men’s. As a result, much less is known about the tion is to raise awareness about the treatment needs of prevalence and patterns of women’s substance use, and women and to provide tools, suggestions and practical *United Nations publication, Sales No. E.03.XI.II. v Substance Abuse Treatment and Care for Women: Case Studies and Lessons Learned examples for overcoming access barriers, engaging • Presentations and discussions that took place at a women in treatment and providing treatment that is meeting of representatives of case study projects, responsive to the specific needs of women. members of the international panel of experts and staff of the United Nations Office on Drugs and The booklet brings together information from a variety Crime, entitled “Women’s Drug Treatment: Lessons of sources: Learned” held in Vienna, from 15 to 17 December 2003, referred to thereafter in the following chapters • A review of the literature. Published articles and as “the Vienna meeting”. reports were identified through a search of Medline/PubMed, EMbase and PsychInfo databases The present publication is about substance abuse treat- from 1998 to 2003; as well as from web sites of ment for women in general. Though it is recognized international and national bodies and organizations that adolescent women and older adult women have that contain guidelines, full text articles or other rel- specific treatment needs because of their different sub- evant information. Members of an international stance use patterns and life circumstances, treatment panel of experts formed to advise on various phases and rehabilitation issues for these two population of the project and representatives of case studies groups will be addressed in more depth in other publi- included in this booklet were also a rich source of cations of the United Nations Office on Drugs and articles, reports and other information. The litera- Crime in the Drug Abuse Treatment Toolkit series. ture review built on several other recent literature Prevention is an extremely important aspect of address- reviews, particularly the literature review by Gillian ing
Load more

Recommended publications
  • 2019 Ministerial Declaration
    COMMISSION ON NARCOTIC DRUGS VIENNA IMPLEMENTATION OF ALL INTERNATIONAL DRUG POLICY COMMITMENTS Follow-up to the 2019 Ministerial Declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem” UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Commission on Narcotic Drugs IMPLEMENTATION OF ALL INTERNATIONAL DRUG POLICY COMMITMENTS Follow-up to the 2019 Ministerial Declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem” UNITED NATIONS Vienna, 2019 © United Nations, July 2019. All rights reserved, worldwide. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Contents 1. Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem ...............................1 2. Outcome document of the thirtieth special session of the General Assembly, entitled “Our joint commitment to effectively addressing and countering the world drug problem” ..................................................9 3. Joint Ministerial Statement of the 2014 High-Level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem ...............................35 4.
    [Show full text]
  • Amphetamine Sensitization Alters Hippocampal Neuronal Morphology and Memory and Learning Behaviors
    Molecular Psychiatry https://doi.org/10.1038/s41380-020-0809-2 ARTICLE Amphetamine sensitization alters hippocampal neuronal morphology and memory and learning behaviors 1,2,5 1,2 1 Luis Enrique Arroyo-García ● Hiram Tendilla-Beltrán ● Rubén Antonio Vázquez-Roque ● 1 3 3 3 1 Erick Ernesto Jurado-Tapia ● Alfonso Díaz ● Patricia Aguilar-Alonso ● Eduardo Brambila ● Eduardo Monjaraz ● 2 4 1 Fidel De La Cruz ● Antonio Rodríguez-Moreno ● Gonzalo Flores Received: 12 November 2019 / Revised: 29 May 2020 / Accepted: 3 June 2020 © The Author(s), under exclusive licence to Springer Nature Limited 2020 Abstract It is known that continuous abuse of amphetamine (AMPH) results in alterations in neuronal structure and cognitive behaviors related to the reward system. However, the impact of AMPH abuse on the hippocampus remains unknown. The aim of this study was to determine the damage caused by AMPH in the hippocampus in an addiction model. We reproduced the AMPH sensitization model proposed by Robinson et al. in 1997 and performed the novel object recognition test (NORt) to evaluate learning and memory behaviors. After the NORt, we performed Golgi–Cox staining, a 1234567890();,: 1234567890();,: stereological cell count, immunohistochemistry to determine the presence of GFAP, CASP3, and MT-III, and evaluated oxidative stress in the hippocampus. We found that AMPH treatment generates impairment in short- and long-term memories and a decrease in neuronal density in the CA1 region of the hippocampus. The morphological test showed an increase in the total dendritic length, but a decrease in the number of mature spines in the CA1 region. GFAP labeling increased in the CA1 region and MT-III increased in the CA1 and CA3 regions.
    [Show full text]
  • Synthetic Drugs: Overview and Issues for Congress
    Synthetic Drugs: Overview and Issues for Congress Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy Kristin Finklea Specialist in Domestic Security May 3, 2016 Congressional Research Service 7-5700 www.crs.gov R42066 Synthetic Drugs: Overview and Issues for Congress Summary Synthetic drugs, as opposed to natural drugs, are chemically produced in a laboratory. Their chemical structure can be either identical to or different from naturally occurring drugs, and their effects are designed to mimic or even enhance those of natural drugs. When produced clandestinely, they are not typically controlled pharmaceutical substances intended for legitimate medical use. Designer drugs are a form of synthetic drugs. They contain slightly modified molecular structures of illegal or controlled substances, and they are modified in order to circumvent existing drug laws. While the issue of synthetic drugs and their abuse is not new, Congress has demonstrated a renewed concern with the issue. From 2009 to 2011, synthetic drug abuse was reported to have dramatically increased. During this time period, calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids (such as “K2” and “Spice”) and stimulants (such as “bath salts”) increased at what some considered to be an alarming rate. The number of hospital emergency department visits involving synthetic cannabinoids more than doubled from 2010 to 2011. In 2012 and 2013, however, the number of calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids and synthetic stimulants decreased. Calls regarding bath salts have declined each year since 2011, while calls regarding synthetic cannabinoids have increased since the drops in 2012 and 2013.
    [Show full text]
  • Comparison Between Two Methodological Paradigms of Conditioned Place Preference with Methlyphenidate
    East Tennessee State University Digital Commons @ East Tennessee State University Undergraduate Honors Theses Student Works 12-2013 Comparison between Two Methodological Paradigms of Conditioned Place Preference with Methlyphenidate. Bryce D. Watson East Tennessee State University Follow this and additional works at: https://dc.etsu.edu/honors Part of the Psychiatry and Psychology Commons Recommended Citation Watson, Bryce D., "Comparison between Two Methodological Paradigms of Conditioned Place Preference with Methlyphenidate." (2013). Undergraduate Honors Theses. Paper 89. https://dc.etsu.edu/honors/89 This Honors Thesis - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of Digital Commons @ East Tennessee State University. For more information, please contact [email protected]. Watson 1 Comparison between Two Methodological Paradigms of Conditioned Place Preference with Methlyphenidate By Bryce Watson The Honors College Honors in Discipline Program East Tennessee State University Department of Psychology December 9, 2013 Russell Brown, Faculty Mentor David Harker, Faculty Reader Eric Sellers, Faculty Reader Watson 2 Abstract The aim of this thesis is to examine the mechanisms of Methylphenidate (MPH) on Conditioned Place Preference (CPP), a behavioral test of reward. The psychostimulant MPH is therapeutically used in the treatment of ADHD, but has been implicated in many pharmacological actions related to drug addiction and is considered to have abuse potential. Past work in our lab and others have shown substantial sex-differences in the neuropharmacological profile of MPH. Here a discussion of the relevant mechanisms of action of MPH and its relationship to neurotrophins and CPP are reviewed.
    [Show full text]
  • D, Dopamine Receptor Activation Is Necessary for the Induction of Sensitization by Amphetamine in the Ventral Tegmental Area
    The Journal of Neuroscience, April 1, 1996, 76(7):241 l-2420 D, Dopamine Receptor Activation Is Necessary for the Induction of Sensitization by Amphetamine in the Ventral Tegmental Area Paul Vezina Department of Psychiatry, The University of Chicago, Chicago, Illinois 6063 7 Repeated intermittent exposure to amphetamine produces injections of amphetamine. In the second experiment, locomo- long-term enhancements in the ability of this drug to produce tor sensitization induced by infusion of amphetamine into the locomotion and increase extracellular dopamine (DA) in the ventral tegmental area (WA) was blocked when these injections nucleus accumbens (NAcc). Three experiments were con- were preceded by systemic injections of SCH23390. Finally, in ducted to evaluate the role played by D, DA receptors in the experiment three, co-injecting SCH23390, but not its inactive production of these changes in response to amphetamine. Rats enantiomer, with amphetamine into the VTA during preexpo- were preexposed to amphetamine, alone or with a DA receptor sure prevented sensitization of the NAcc DA response to this antagonist, and tested for sensitization l-3 weeks after the last drug. These results indicate that while D, DA receptor activa- drug injection. On the test for sensitization, locomotor (experi- tion is not necessary for the induction of locomotor sensitiza- ments 1 and 2) and NAcc DA (experiment 3) responses of the tion to amphetamine, D, DA receptors located in the VTA play animals to a systemic amphetamine injection were assessed. In a critical role in the development of sensitized locomotor and the first experiment, systemic injections of the D, DA receptor NAcc DA response to this drug.
    [Show full text]
  • Nonparaphilic Sexual Addiction Mark Kahabka
    The Linacre Quarterly Volume 63 | Number 4 Article 2 11-1-1996 Nonparaphilic Sexual Addiction Mark Kahabka Follow this and additional works at: http://epublications.marquette.edu/lnq Part of the Ethics and Political Philosophy Commons, and the Medicine and Health Sciences Commons Recommended Citation Kahabka, Mark (1996) "Nonparaphilic Sexual Addiction," The Linacre Quarterly: Vol. 63: No. 4, Article 2. Available at: http://epublications.marquette.edu/lnq/vol63/iss4/2 Nonparaphilic Sexual Addiction by Mr. Mark Kahabka The author is a recent graduate from the Master's program in Pastoral Counseling at Saint Paul University in Ottawa, Ontario, Canada. Impulse control disorders of a sexual nature have probably plagued humankind from its beginnings. Sometimes classified today as "sexual addiction" or "nonparaphilic sexual addiction,"l it has been labeled by at least one professional working within the field as "'The World's Oldest/Newest Perplexity."'2 Newest, because for the most part, the only available data until recently has come from those working within the criminal justice system and as Patrick Carnes points out, "they never see the many addicts who have not been arrested."3 By definition, both paraphilic4 and nonparaphilic sexual disorders "involve intense sexual urges and fantasies" and which the "individual repeatedly acts on these urges or is highly distressed by them .. "5 Such disorders were at one time categorized under the classification of neurotic obsessions and compulsions, and thus were usually labeled as disorders of an obsessive compulsive nature. Since those falling into this latter category, however, perceive such obessions and compulsions as "an unwanted invasion of consciousness"6 (in contrast to sexual impulse control disorders, which are "inherently pleasurable and consciously desired"7) they are now placed under the "impulse control disorder" category.s To help clarify the distinction: The purpose of the compulsions is to reduce anxiety, which often stems from unwanted but intrusive thoughts.
    [Show full text]
  • Molecular Mechanisms of Addiction
    Molecular Mechanisms of Addiction Eric J. Nestler Nash Family Professor The Friedman Brain Institute Medical Model of Addiction • Pathophysiology - To identify changes that drugs produce in a vulnerable brain to cause addiction. • Individual Risk - To identify specific genes and non-genetic factors that determine an individual’s risk for (or resistance to) addiction. - About 50% of the risk for addiction is genetic. Only through an improved understanding of the biology of addiction will it be possible to develop better treatments and eventually cures and preventive measures. Scope of Drug Addiction • 25% of the U.S. population has a diagnosis of drug abuse or addiction. • 50% of U.S. high school graduates have tried an illegal drug; use of alcohol and tobacco is more common. • >$400 billion incurred annually in the U.S. by addiction: - Loss of life and productivity - Medical consequences (e.g., AIDS, lung cancer, cirrhosis) - Crime and law enforcement Diverse Chemical Substances Cause Addiction • Opiates (morphine, heroin, oxycontin, vicodin) • Cocaine • Amphetamine and like drugs (methamphetamine, methylphenidate) • MDMA (ecstasy) • PCP (phencyclidine or angel dust; also ketamine) • Marijuana (cannabinoids) • Tobacco (nicotine) • Alcohol (ethanol) • Sedative/hypnotics (barbiturates, benzodiazepines) Chemical Structures of Some Drugs of Abuse Cocaine Morphine Ethanol Nicotine ∆9-tetrahydrocannabinol Drugs of Abuse Use of % of US population as weekly users 100 25 50 75 0 Definition of Drug Addiction • Loss of control over drug use. • Compulsive drug seeking and drug taking despite horrendous adverse consequences. • Increased risk for relapse despite years of abstinence. Definition of Drug Addiction • Tolerance – reduced drug effect after repeated use. • Sensitization – increased drug effect after repeated use.
    [Show full text]
  • Treatment of Patients with Substance Use Disorders Second Edition
    PRACTICE GUIDELINE FOR THE Treatment of Patients With Substance Use Disorders Second Edition WORK GROUP ON SUBSTANCE USE DISORDERS Herbert D. Kleber, M.D., Chair Roger D. Weiss, M.D., Vice-Chair Raymond F. Anton Jr., M.D. To n y P. G e o r ge , M .D . Shelly F. Greenfield, M.D., M.P.H. Thomas R. Kosten, M.D. Charles P. O’Brien, M.D., Ph.D. Bruce J. Rounsaville, M.D. Eric C. Strain, M.D. Douglas M. Ziedonis, M.D. Grace Hennessy, M.D. (Consultant) Hilary Smith Connery, M.D., Ph.D. (Consultant) This practice guideline was approved in December 2005 and published in August 2006. A guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available in the Psychiatric Practice section of the APA web site at www.psych.org. 1 Copyright 2010, American Psychiatric Association. APA makes this practice guideline freely available to promote its dissemination and use; however, copyright protections are enforced in full. No part of this guideline may be reproduced except as permitted under Sections 107 and 108 of U.S. Copyright Act. For permission for reuse, visit APPI Permissions & Licensing Center at http://www.appi.org/CustomerService/Pages/Permissions.aspx. AMERICAN PSYCHIATRIC ASSOCIATION STEERING COMMITTEE ON PRACTICE GUIDELINES John S. McIntyre, M.D., Chair Sara C. Charles, M.D., Vice-Chair Daniel J. Anzia, M.D. Ian A. Cook, M.D. Molly T. Finnerty, M.D. Bradley R. Johnson, M.D. James E. Nininger, M.D. Paul Summergrad, M.D. Sherwyn M.
    [Show full text]
  • The Clinical Toxicology of Gamma-Hydroxybutyrate, Gamma-Butyrolactone and 1,4-Butanediol
    Clinical Toxicology (2012), 50: 458–470 Copyright © 2012 Informa Healthcare USA, Inc. ISSN: 1556-3650 print / 1556-9519 online DOI: 10.3109/15563650.2012.702218 REVIEW ARTICLE The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol LEO J SCHEP 1 , KAI KNUDSEN 2 , ROBIN J SLAUGHTER 1 , J ALLISTER VALE 3 , and BRUNO MÉGARBANE 4 1 National Poisons Centre, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand 2 Department of Anesthesia and Intensive Care Medicine, Surgical Sciences, Blå Stråket 5, Sahlgrenska University Hospital, Gothenburg, Sweden 3 National Poisons Information Service (Birmingham Unit) and West Midlands Poisons Unit, City Hospital, Birmingham, UK; School of Biosciences and College of Medical and Dental Sciences, University of Birmingham, Birmingham,UK 4 Hôpital Lariboisière, Réanimation Médicale et Toxicologique, INSERM U705, Université Paris-Diderot, Paris, France Introduction. Gamma-hydroxybutyrate (GHB) and its precursors, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), are drugs of abuse which act primarily as central nervous system (CNS) depressants. In recent years, the rising recreational use of these drugs has led to an increasing burden upon health care providers. Understanding their toxicity is therefore essential for the successful management of intoxicated patients. We review the epidemiology, mechanisms of toxicity, toxicokinetics, clinical features, diagnosis, and management of poisoning due to GHB and its analogs and discuss the features and management of GHB withdrawal. Methods. OVID MEDLINE and ISI Web of Science databases were searched using the terms “ GHB, ” “ gamma-hydroxybutyrate, ” “ gamma-hydroxybutyric acid, ” “ 4-hydroxybutanoic acid, ” “ sodium oxybate, ” “ gamma-butyrolactone, ” “ GBL, ” “ 1,4-butanediol, ” and “ 1,4-BD ” alone and in combination with the keywords “ pharmacokinetics, ” “ kinetics, ” “ poisoning, ” “ poison, ” “ toxicity, ” “ ingestion, ” “ adverse effects, ” “ overdose, ” and “ intoxication.
    [Show full text]
  • The Long History of Indigenous Rock, Metal, and Punk
    UNIVERSITY OF CALIFORNIA Los Angeles Not All Killed by John Wayne: The Long History of Indigenous Rock, Metal, and Punk 1940s to the Present A thesis submitted in partial satisfaction of the requirements for the degree Master of Arts in American Indian Studies by Kristen Le Amber Martinez 2019 © Copyright by Kristen Le Amber Martinez 2019 ABSTRACT OF THESIS Not All Killed by John Wayne: Indigenous Rock ‘n’ Roll, Metal, and Punk History 1940s to the Present by Kristen Le Amber Martinez Master of Arts in American Indian Studies University of California Los Angeles, 2019 Professor Maylei Blackwell, Chair In looking at the contribution of Indigenous punk and hard rock bands, there has been a long history of punk that started in Northern Arizona, as well as a current diverse scene in the Southwest ranging from punk, ska, metal, doom, sludge, blues, and black metal. Diné, Apache, Hopi, Pueblo, Gila, Yaqui, and O’odham bands are currently creating vast punk and metal music scenes. In this thesis, I argue that Native punk is not just a cultural movement, but a form of survivance. Bands utilize punk and their stories as a conduit to counteract issues of victimhood as well as challenge imposed mechanisms of settler colonialism, racism, misogyny, homophobia, notions of being fixed in the past, as well as bringing awareness to genocide and missing and murdered Indigenous women. Through D.I.Y. and space making, bands are writing music which ii resonates with them, and are utilizing their own venues, promotions, zines, unique fashion, and lyrics to tell their stories.
    [Show full text]
  • Strengths-Based Treatment of Substance Use Disorders: a Critical Analysis of the Literature
    Pepperdine University Pepperdine Digital Commons Theses and Dissertations 2016 Strengths-based treatment of substance use disorders: a critical analysis of the literature Jennifer A. Berg Follow this and additional works at: https://digitalcommons.pepperdine.edu/etd Recommended Citation Berg, Jennifer A., "Strengths-based treatment of substance use disorders: a critical analysis of the literature" (2016). Theses and Dissertations. 729. https://digitalcommons.pepperdine.edu/etd/729 This Dissertation is brought to you for free and open access by Pepperdine Digital Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of Pepperdine Digital Commons. For more information, please contact [email protected], [email protected], [email protected]. Pepperdine University Graduate School of Education and Psychology STRENGTHS-BASED TREATMENT OF SUBSTANCE USE DISORDERS: A CRITICAL ANALYSIS OF THE LITERATURE A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Psychology by Jennifer A. Berg October, 2016 Amy Tuttle, Ph. D. – Dissertation Chairperson This clinical dissertation, written by Jennifer A Berg under the guidance of a Faculty Committee and approved by its members, has been submitted to and accepted by the Graduate Faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PSYCHOLOGY Doctoral Committee: Amy Tuttle, Ph.D., Chairperson Carrie Castaneda-Sound, Ph.D. Natasha Thapar-Olmos, Ph.D TABLE OF CONTENTS
    [Show full text]
  • "Authenticity" in Rap Music by Consumers."
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2010 "Rapping About Authenticity": Exploring the Differences in Perceptions of "Authenticity" in Rap Music by Consumers." James L. Wright UTK, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Critical and Cultural Studies Commons, Ethnomusicology Commons, Social Psychology and Interaction Commons, and the Sociology of Culture Commons Recommended Citation Wright, James L., ""Rapping About Authenticity": Exploring the Differences in Perceptions of "Authenticity" in Rap Music by Consumers.". " PhD diss., University of Tennessee, 2010. https://trace.tennessee.edu/utk_graddiss/760 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by James L. Wright entitled ""Rapping About Authenticity": Exploring the Differences in Perceptions of "Authenticity" in Rap Music by Consumers."." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Sociology. Suzaanne B. Kurth, Major Professor We have read this dissertation and recommend its acceptance: Robert Emmet Jones; Hoan Bui; Debora Baldwin Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) To the Graduate Council: I am submitting herewith a dissertation written by James L.
    [Show full text]